Ab Initio Pharma Proudly Sponsors PDC 2025!

Ab Initio Pharma is proud to sponsor the upcoming 2nd Pharmaceutical Development Conference (PDC 2025), taking place on 9 September 2025 in Sydney.

Hosted by Aphex Pharma Solutions, PDC is fast becoming a key event for pharmaceutical innovators, formulation scientists, and regulatory experts across Australia and beyond. The conference brings together thought leaders and industry professionals to discuss emerging trends, development strategies, and solutions that shape the future of drug development.

As a leading Australian CDMO, Ab Initio Pharma is committed to advancing pharmaceutical innovation. Our sponsorship reflects our ongoing support for knowledge sharing, industry growth, and collaboration across the development pipeline, from preclinical formulation to GMP manufacturing and clinical trial supply.

We look forward to connecting with delegates, sharing insights into our latest projects, and discussing how we help bring complex dosage forms (including inhalation, nasal, topical, and oral) into the clinic efficiently and compliantly.

👉 For more information, visit: aphexpharma.com/pdc